These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27526785)

  • 1. miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.
    Rasmussen MH; Lyskjær I; Jersie-Christensen RR; Tarpgaard LS; Primdal-Bengtson B; Nielsen MM; Pedersen JS; Hansen TP; Hansen F; Olsen JV; Pfeiffer P; Ørntoft TF; Andersen CL
    Nat Commun; 2016 Aug; 7():12436. PubMed ID: 27526785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells.
    Liang H; Xu Y; Zhang Q; Yang Y; Mou Y; Gao Y; Chen R; Chen C; Dai P
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):725-736. PubMed ID: 30861353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
    Wu YZ; Lin HY; Zhang Y; Chen WF
    J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer.
    Rasmussen MH; Jensen NF; Tarpgaard LS; Qvortrup C; Rømer MU; Stenvang J; Hansen TP; Christensen LL; Lindebjerg J; Hansen F; Jensen BV; Hansen TF; Pfeiffer P; Brünner N; Ørntoft TF; Andersen CL
    Mol Oncol; 2013 Jun; 7(3):637-46. PubMed ID: 23506979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of microRNA-21-3p suppresses proliferation as well as invasion and induces apoptosis by targeting RNA-binding protein with multiple splicing through Smad4/extra cellular signal-regulated protein kinase signalling pathway in human colorectal cancer HCT116 cells.
    Hou N; Guo Z; Zhao G; Jia G; Luo B; Shen X; Bai Y
    Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):729-741. PubMed ID: 29542167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.
    Jiang T; Ye L; Han Z; Liu Y; Yang Y; Peng Z; Fan J
    J Exp Clin Cancer Res; 2017 Sep; 36(1):131. PubMed ID: 28938919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
    Tan S; Shi H; Ba M; Lin S; Tang H; Zeng X; Zhang X
    Int J Mol Med; 2016 Apr; 37(4):1030-8. PubMed ID: 26935807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
    Zhao D; Sui Y; Zheng X
    Oncol Rep; 2016 Feb; 35(2):1075-82. PubMed ID: 26718987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
    Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells.
    Chiu SJ; Chao JI; Lee YJ; Hsu TS
    Toxicol Lett; 2008 Jun; 179(2):63-70. PubMed ID: 18499365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
    Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
    Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer.
    Xiao Z; Liu Y; Li Q; Liu Q; Liu Y; Luo Y; Wei S
    Cancer Chemother Pharmacol; 2021 Dec; 88(6):1021-1031. PubMed ID: 34599680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-422a targets MAPKK6 and regulates cell growth and apoptosis in colorectal cancer cells.
    Li P; Li Q; Zhang Y; Sun S; Liu S; Lu Z
    Biomed Pharmacother; 2018 Aug; 104():832-840. PubMed ID: 29566993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
    Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z
    Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase.
    Zhou Y; Wan G; Spizzo R; Ivan C; Mathur R; Hu X; Ye X; Lu J; Fan F; Xia L; Calin GA; Ellis LM; Lu X
    Mol Oncol; 2014 Feb; 8(1):83-92. PubMed ID: 24145123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression.
    Bullock MD; Pickard KM; Nielsen BS; Sayan AE; Jenei V; Mellone M; Mitter R; Primrose JN; Thomas GJ; Packham GK; Mirnezami AH
    Cell Death Dis; 2013 Jun; 4(6):e684. PubMed ID: 23788041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
    Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Role for MiR-520a-3p in Regulating EGFR Expression in Colorectal Cancer.
    Zhang R; Liu R; Liu C; Niu Y; Zhang J; Guo B; Zhang CY; Li J; Yang J; Chen X
    Cell Physiol Biochem; 2017; 42(4):1559-1574. PubMed ID: 28738328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.